According to a study published online in the journal Diabetes Care, higher serum 25-hydroxyvitamin D (25OHD) levels have a lower risk of type 2 diabetes (T2D). Researchers at Peking University investigated whether there is an expected association between 25OHD and T2D event risk, and whether there is an association that changes due to sleep behavior.
Median time of follow-up 8. In this year, a total of 6,940 T2D events occurred. The researchers found that serum 25OHD was significantly associated with reducing the risk of T2D (the adjusted risk ratio increased by 0.88 per 10 mol/L). Regarding the risk of T2D, there is also an important interaction between 25OHD and overall sleep patterns. The negative correlation between high 25OHD and T2D was more pronounced in participants with healthier sleep patterns. Daytime sleepiness showed the strongest interaction with 25OHD. Compared with participants with excessive daytime sleepiness, participants with less daytime sleepiness had a lower risk of T2D and a higher 25OHD.
The author wrote: "Repeat verification, our findings may affect the development of T2D prevention strategies aimed at improving vitamin D supplements in people with sleep disorders, especially those who are sleepy during the day."